04.06.20131913
Women with gestational diabetes who have a cluster of symptoms typical of metabolic syndrome are more likely to go on to develop diabetes over 10 years, researchers found.
03.06.20131940
Mineralocorticoid receptor antagonists (MRAs) improve outcomes in patients with heart failure and reduced left ventricular ejection fraction (HFrEF), but their use is limited by hyperkalaemia and/or worsening renal function (WRF).
31.05.20132057
To examine the risk of new onset diabetes among patients treated with different HMG-CoA reductase inhibitors (statins).
30.05.20132066
The vascular and gastrointestinal effects of non-steroidal anti-inflammatory drugs (NSAIDs), including selective COX-2 inhibitors (coxibs) and traditional non-steroidal anti-inflammatory drugs (tNSAIDs), are not well characterised, particularly in patients at increased risk of vascular disease.
29.05.20131997
Patients taking aspirin or warfarin (Coumadin) for prevention after a stroke don't need to stop the drug for dental procedures and probably can stay on it for most other minor medical procedures, the American Academy of Neurology recommended.
28.05.20131959
Rivaroxaban (Xarelto, Bayer ) has been approved in Europe for the prevention of atherothrombotic events (cardiovascular death, myocardial infarction or stroke) following an acute coronary syndrome (ACS).
27.05.20132125
What is the predictive value of tumor marker carbohydrate antigen 125 (CA125) before and after transcatheter aortic valve implantation (TAVI) for all-cause death and a composite endpoint of death, admission for heart failure, myocardial infarction, and stroke (major adverse cardiac events [MACE])?